Nikhil Joshi, MD

Nikhil Joshi, MD, is an Associate Professor at Rush University, where he specializes in oncology and radiation oncology. His research focuses on radiation therapy for head and neck cancers, including nasopharyngeal carcinoma, mucosal melanoma, and recurrent or advanced squamous cell carcinoma. His recent work includes a 2024 JAMA Oncology study on intensity-modulated reirradiation combined with nivolumab for recurrent head and neck cancer, alongside 2025 publications on Merkel cell carcinoma and cutaneous malignancies. He integrates epidemiology and surgical oncology perspectives into his treatment research, contributing to advances in cancer care.